Beranda › Hidradenitis Suppurativa › Massachusetts
Uji klinis Hidradenitis Suppurativa di Massachusetts
10 studi untuk Hidradenitis Suppurativa mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
A Study to Investigate Efficacy and Safety With SAR445399 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa
- Beth Israel Deaconess Medical Center - Boston- Site Number : 8400001, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07225569Safety and Efficacy of Soquelitinib in Adults With Hidradenitis Suppurativa
- Clinical Site 3, Boston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07828860A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
- Up0122 104, Boston
Menerima pesertaFase 1
Usia 18 ke atas · Wanita · Diperbarui 18 Sep 2026 · NCT06888193Rollover Study for Participants Previously Enrolled in Clinical Trials of Povorcitinib
- Investigative Site US030, Boston
- Investigative Site US048, Brighton
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Sep 2026 · NCT06855498Targeting Nociceptors in Hidradenitis Suppurativa
- University of Massachusetts Chan Medical School, Worcester
Menerima pesertaStudi observasional
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT05403710Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa
- Boston Childrens Hospital, Boston
Menerima pesertaFase 2
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07213973A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
- Beth Israel Deaconess Medical Center, Boston
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT07384975The Safety and Efficacy of Roflumilast Foam in HS
- Beth Israel Deaconess Medical Center, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT07263230A Long-Term Follow-Up Observational Study to Evaluate Safety in Subjects Who Have Received a Gene-Modified Regulatory T Cell (Treg) Therapeutic
- Tufts University, Boston
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Menerima pesertaStudi observasional
Usia 18 hingga 71 · Semua jenis kelamin · Diperbarui 16 Apr 2026 · NCT07123038A Study of Zasocitinib in Adults With Hidradenitis Suppurativa
- Beth Israel Deaconess Medical Center, Boston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mar 2026 · NCT07244263Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.